31 December 2024

Circular No. 11436 for the year 2024 Revoke the registration suspension of Production Lines of Medochemie Products.

Reference: CIR-2024-00000255

To all Health, facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the Circular issued by the MOHAP for perusal and adhere to what is stated

 

Circular No. 11436 for the year 2024 Revoke the registration suspension of Production Lines of Medochemie Products.

 

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Medochemie Ltd رفع تعليق تسجيل خطوط الانتاج ومنتجات مصنع.pdf:

View Document